Results Of 3,882 BRCA1 and 1,509 BRCA2 mutation carriers, 53% and 71%, respectively, had ever used hormonal contraceptives for at least 1 year (median cumulative duration of use, 4.8 and 5.7 years, ...

Invitae Presents New Data Demonstrating High Concordance of Variant Classifications for BRCA1/2 Across Major Clinical Testing Laboratories -- Platform talk given at 2016 ACMG Annual Clinical ...